ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 4.04% of TCON shares are held by financial institutions. ETF PORTFOLIO PARTNERS, INC. is the top corporate investor, holding 24.64K shares valued at $10.59K. A 0.08% stake in TRACON Pharmaceuticals, Inc. is owned by the company. SPIDERROCK ADVISORS, LLC owns 22.98K shares valued at $8.30K, which translates its holding of 0.07% of the stake in the company.
Among the TCON insiders holding of 1.73% of the stake in company, OPALEYE MANAGEMENT INC., 10 percent owner, holds the largest shares of 4.32M. IKARIAN CAPITAL, LLC, 10 percent owner, is the second largest TCON insider with ownership of 2.72M shares. THEUER CHARLES, President and CEO, stands third with possession of 399.42K shares of that stake.